Sorry...!!! You are not eligible for this website
AF Peptides logo
Age Verification

You must be 21+ years old to visit our website. Select your preference below.

Important Disclaimer: This product is sold strictly for research and laboratory use only and is not intended for human or animal consumption, medical, diagnostic, or therapeutic purposes.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Tesamorelin 20mg

$149.99

SKU: AFP-TESA-20MG-VL

12 in stock (can be backordered)

View lab report (COA)

Research Highlights

Tesamorelin is a stabilized synthetic analogue of growth hormone-releasing hormone (GHRH) commonly studied in research involving:

  • GHRH-receptor signaling
  • Pulsatile growth hormone release
  • Growth hormone and IGF-1-associated pathways
  • Adipose-tissue metabolism and body-composition models
  • Neuroendocrine feedback and pituitary-response research

About Tesamorelin

Tesamorelin is a 44-amino-acid synthetic analogue of human GHRH. In simple terms, researchers use it to study signaling between the hypothalamic-pituitary axis and the growth hormone system. It acts at the GHRH receptor on pituitary somatotroph cells, activating intracellular pathways that include cyclic AMP and protein kinase A and promoting endogenous growth hormone release.

Unlike compounds that act at the ghrelin receptor, Tesamorelin works through the GHRH receptor and retains the broader regulatory context of pituitary growth hormone secretion. Its N-terminal trans-3-hexenoyl modification was designed to improve resistance to enzymatic degradation compared with native GHRH, making the molecule useful in studies of sustained GHRH-receptor activity.

Tesamorelin has been investigated clinically in specific medical populations, including research involving excess abdominal fat in adults with HIV-associated lipodystrophy. Those findings are population-, formulation-, and protocol-specific and should not be generalized to unrelated uses. The presence of clinical research or an approved pharmaceutical product does not establish that an independently sold research reagent is equivalent, approved, safe, or effective for human use.

Product Details

  • Compound: Tesamorelin
  • Strength: 20mg
  • Compound class: Stabilized synthetic GHRH analogue
  • Peptide length: 44 amino acids
  • Primary research target: GHRH receptor
  • Form: Lyophilized powder
  • Testing: Product-specific certificate of analysis available

IMPORTANT DISCLAIMER — FOR LABORATORY RESEARCH USE ONLY

This product is intended exclusively for laboratory research purposes. It is not intended for human or animal consumption or for human or veterinary use, administration, ingestion, injection, inhalation, implantation, topical application, compounding, medical use, diagnostic use, or therapeutic use.

This product is not approved by the U.S. Food and Drug Administration for human or veterinary use. It is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. AF Peptides makes no representation regarding its safety, effectiveness, or suitability for any clinical, therapeutic, diagnostic, personal, or household application.